George W. Lloyd, EVP, Investments & GC at Royalty Pharma plc (RPRX), sold 110,000 shares at $46.46 ($5.1M) on 2021-06-10, disclosed to the SEC on 2021-06-14.
Open-market sale of $5.1M RPRX by EVP, Investments & GC. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.45 | 10,000 | $465K | 9.1% |
| 2 | $46.46 | 20,000 | $929K | 18.2% |
| 3 | $46.52 | 40,000 | $1.9M | 36.4% |
| 4 | $46.52 | 40,000 | $1.9M | 36.4% |
| Total | $46.50 avg | 110,000 | $5.1M | 100% |
| Filing → |
| RPRX | SELL | 2025-11-21 | $10.4M | — | Filing → |
| RPRX | SELL | 2023-06-06 | $13.0M | — | Filing → |
| RPRX | SELL | 2023-03-30 | $4.7M | — | Filing → |